As per the report, the drug discovery market size was US$ 74.96 billion in 2021. It is projected to grow 161.76 billion by 2030 at a CAGR of 8.9% in the forecast period.
The global drug discovery market is significantly driven by the rising prevalence of various chronic diseases, rising healthcare expenditure, and patent expiration of certain popular drugs across the globe. The global population is facing growing burden of various diseases such as cardiovascular diseases, diabetes, cancer, respiratory diseases, and neurological disorders, which is significantly fueling the demand for the new and innovative drugs. The exponentially growing pharmaceutical industry owing to the rapid growth of the biopharmaceuticals is expected to drive the drug discovery market in the forthcoming years.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1464
Market Overview
A recent study by Precedence Research on the drug discovery market offers a forecast for 2021 and 2030. The study analyzes crucial trends that are currently determining the growth of the drug discovery market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of drug discovery. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.
A detailed assessment of the drug discovery market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the drug discovery market along with their product portfolio enhances the reliability of this comprehensive research study.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Key Points
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Research Methodology
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Competition Landscape
In the final section of the report on the global drug discovery market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global drug discovery market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the drug discovery marketplace.
Some of the prominent players in the global drug discovery market include:
- Pfizer Inc.
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Agilent Technologies Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Bayer AG
- Abbott Laboratories Inc.
- AstraZeneca PLC
- Shimadzu Corp
Market Segmentation
Segments of the global drug discovery market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global drug discovery market.
Market Segments as below:
By Drug Type
- Small Molecule
- Large Molecule
By End User
- Pharmaceutical Companies
- CROs
- Others
By Technology
- High Throughput Screening
- Pharmacogenomics
- Combinatorial Chemistry
- Nanotechnology
- Other Technologies
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- MEA
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Drug Discovery Market
5.1. COVID-19 Landscape: Drug Discovery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Drug Discovery Market, By End User
8.1. Drug Discovery Market, by End User Type, 2021-2030
8.1.1. Pharmaceutical Companies
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. CROs
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Drug Discovery Market, By Drug Type
9.1. Drug Discovery Market, by Drug Type, 2021-2030
9.1.1. Small Molecule
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Large Molecule
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Drug Discovery Market, By Technology
10.1. Drug Discovery Market, by Technology, 2021-2030
10.1.1. High Throughput Screening
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Pharmacogenomics
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Combinatorial Chemistry
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Nanotechnology
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Other Technologies
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Drug Discovery Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by End User (2019-2030)
11.1.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.1.3. Market Revenue and Forecast, by Technology (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.1.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Technology (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by End User (2019-2030)
11.2.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.2.3. Market Revenue and Forecast, by Technology (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.2.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Technology (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by End User (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Technology (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by End User (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Technology (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by End User (2019-2030)
11.3.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.3.3. Market Revenue and Forecast, by Technology (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.3.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Technology (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by End User (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Technology (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by End User (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Technology (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.4.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Technology (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by End User (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Technology (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by End User (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Technology (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.5.3. Market Revenue and Forecast, by Technology (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by End User (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.5.4.3. Market Revenue and Forecast, by Technology (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by End User (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Technology (2019-2030)
Chapter 12. Company Profiles
12.1. Pfizer Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline PLC
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck & Co. Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Agilent Technologies Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Eli Lilly and Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. F. Hoffmann-La Roche Ltd
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bayer AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Abbott Laboratories Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. AstraZeneca PLC
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Shimadzu Corp
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research's drug discovery market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1464
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments